Geleta Daniel, Abebe Gemeda, Tilahun Tsion, Ahmed Hunde, Workneh Netsanet, Beyene Getenet
School of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma University, Jimma, Oromia, Ethiopia.
School of Medical Laboratory Sciences, Mycobacteriology Research Center, Institute of Health, Jimma University, Jimma, Oromia, Ethiopia.
BMC Infect Dis. 2024 Dec 18;24(1):1424. doi: 10.1186/s12879-024-10312-4.
Bacteremia is prevalent in neonates, largely attributed to factors inherent in the neonatal period. However, the prevalence of proven bacteremia in Ethiopian neonates has not been previously synthesized. Accordingly, this systematic review and meta-analysis aimed to analyze the prevalence of bacteremia and pathogen profiles in neonates hospitalized for clinical sepsis in Ethiopia.
This systematic review and meta-analysis followed the preferred reporting items for systematic review and meta-analysis (PRISMA) 2020. The literature search was conducted across five databases including PubMed, Google Scholar, Web of Science, Science Direct, and Research for Life spanning from January 2015 to July 2023. The search strategy used MeSH terms and involved screening titles and abstracts, reviewing full-text articles, and including only observational studies published in English within the specified timeframe. Data extraction and quality assessment were performed by three experienced reviewers using a validated data collection tool and the Joanna Briggs Institute quality assessment tool, respectively. The prevalence of neonatal bacteremia was determined through a random effects model, with heterogeneity among studies assessed using the Q statistic and the I statistic. Publication bias was evaluated using a funnel plot and Egger's regression test, and STATA version 16.0 was used for all analysis at 95% confidence level.
A meta-analysis of nine studies revealed a bacteremia prevalence of 40.0% (95% CI: 34.0-46.0%). Subgroup analysis indicated variations in prevalence based on regions and study designs, with Oromia at 44.0% (95% CI: 28.0, 61.0%) and Amhara at 39.0% (95% CI: 27.0, 51.0%). Longitudinal studies exhibited a higher prevalence (47.0%, 95% CI: 27.0-68.0%) compared to cross-sectional designs (38.0%, 95% CI: 32.0-44.0%). Gram-negative bacteria were identified as the predominant etiological agents, representing 59.5% (95% CI: 56.8-62.3%) of cases. Among the bacterial species, Staphylococcus aureus emerged as the most prevalent (20.0%, 95% CI: 18.0%, 22.0%), followed by coagulase-negative staphylococci and Klebsiella pneumoniae, each contributing to 17.0% (95% CI: 15.0%, 20.0%) of bacteremia cases.
The study revealed a significant high prevalence of bacteremia, with differences noted across regions and study designs. Key pathogens identified were Staphylococcus aureus, Klebsiella pneumoniae and coagulase-negative staphylococci. It is advisable to implement surveillance systems, targeted prevention strategies, diagnostic stewardship, and further research on regional variations and bacterial profiles to effectively enhance the ominous future.
菌血症在新生儿中很常见,这在很大程度上归因于新生儿期的固有因素。然而,此前尚未综合分析过埃塞俄比亚新生儿中确诊菌血症的患病率。因此,本系统评价和荟萃分析旨在分析埃塞俄比亚因临床败血症住院的新生儿中菌血症的患病率和病原体谱。
本系统评价和荟萃分析遵循系统评价和荟萃分析的首选报告项目(PRISMA)2020。在包括PubMed、谷歌学术、科学网、科学Direct和生命研究在内的五个数据库中进行文献检索,检索时间跨度为2015年1月至2023年7月。检索策略使用医学主题词,包括筛选标题和摘要、审阅全文文章,并且仅纳入在指定时间范围内以英文发表的观察性研究。分别由三位经验丰富的审阅者使用经过验证的数据收集工具和乔安娜·布里格斯研究所质量评估工具进行数据提取和质量评估。通过随机效应模型确定新生儿菌血症的患病率,使用Q统计量和I统计量评估研究之间的异质性。使用漏斗图和埃格回归检验评估发表偏倚,所有分析均使用STATA 16.0版本,置信水平为95%。
对九项研究的荟萃分析显示菌血症患病率为40.0%(95%置信区间:34.0 - 46.0%)。亚组分析表明,患病率因地区和研究设计而异,奥罗米亚地区为44.0%(95%置信区间:28.0,61.0%),阿姆哈拉地区为39.0%(95%置信区间:27.0,51.0%)。与横断面设计(38.0%;95%置信区间:32.0 - 44.0%)相比,纵向研究的患病率更高(47.0%;95%置信区间:27.0 - 68.0%)。革兰氏阴性菌被确定为主要病原体,占病例的59.5%(95%置信区间:56.8 - 62.3%)。在细菌种类中,金黄色葡萄球菌最为常见(20.0%;95%置信区间:18.0%,22.0%),其次是凝固酶阴性葡萄球菌和肺炎克雷伯菌,各占菌血症病例的17.0%(95%置信区间:15.0%,20.0%)。
该研究显示菌血症患病率显著较高,不同地区和研究设计存在差异。确定的主要病原体为金黄色葡萄球菌、肺炎克雷伯菌和凝固酶阴性葡萄球菌。建议实施监测系统、针对性预防策略、诊断管理,并进一步研究区域差异和细菌谱,以有效改善严峻的未来形势。